Pfizer to add Wyeth directors to board

A regulatory filing made yesterday reveals more juicy details about the Pfizer-Wyeth deal: Pfizer will add two Wyeth directors to its board, the Associated Press reports, and if Wyeth backs out of the deal, it would have to pay a breakup fee of up to $2 billion. As you know, Pfizer's breakup fee is more than double that, at $4.5 billion. Report